Low activity of manganese superoxide dismutase (MnSOD) in blood of lung cancer patients with smoking history: Relationship to oxidative stress

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 11, 2011, Pages 3049-3053

  Margaret, Ay Ly ^a   Syahruddin, Elisna ^b   Wanandi, Septelia Inawati ^b  

^a ATMA JAYA CATHOLIC UNIVERSITY OF INDONESIA   (Indonesia)

^b UNIVERSITY OF INDONESIA   (Indonesia)

Author keywords

Carbonyl; Indonesia; Lipid peroxidation; Lung cancer; MnSOD activity; Smoking

Indexed keywords

EID: 84863313953     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Abdi Susanto (2006). Perokok waspadai kanker paru. Senior [cited 2008 June 15]. Available from: http://www.kankerparu.org/main/index.php.
2. Bag A, Bag N (2008). Target sequence polymorphism of human manganese superoxide dismutase gene and its association with cancer risk: a review. Cancer Epidemiol Biomarkers Prev, 17, 3298-305.
3. Berlett BS, Stadtman ER (1997). Protein oxidation in aging, disease, and oxidative stress. J Biol Chem, 272, 20313-6.
4. Clair DS (2004). Manganese superoxide dismutase: genetic variation and regulation. J Nutr, 134, 3190S-1S.
5. Clerch LB, Massaro D, Berkovich A (1998). Molecular mechanism of antioxidant enzyme expression in lung during exposure to and recovery from hyperoxia. Am J Physiol, 274, L313-9.
6. Güney Y, Bilgihan A, Ciftçi TU, et al (2004). Serum malondialdehyde levels and peroxide dismutase activities in pulmonary tuberculosis and lung cancer. Meslek Yuksekokulu Dergisi, 6, 33-8.
7. Harju T, Wiik RK, Sirvio R, et al (2004). Manganese superoxide dismutase is incresed in the airways of smokers' lungs. EurRespir J, 24, 765-71.
8. Husain AN, Kumar V (2004). The lung. In: Robbins, Cotran. Pathologic basic of disease 7th edition. UK: Elsevier Saunders, p.757-764.
9. Ho JC, CW Judith, SM Mary, et al (2006). Manganese superoxide dismutase and catalase genetic polymorphism, activity levels, and lung cancer risk in Chinese in Hong Kong. J Thorac Oncol, 1, 648-53.
10. Ho JC, Chan YM, Ho SP, et al (2007). Disturbance of systemic antioxidant profile in nonsmall cell lung carcinoma. Eur Respir J, 29, 273-8.
11. Ho JC, Zheng S, Comhair AAS, et al (2001). Differential expression of manganese superoxide dismutase and catalase in lung cancer. Cancer Res, 1, 8578-85.
12. Uzun K, Vural H, Ozturk T, et al (2000). Diagnostic value of lipid peroxidation in lung cancer. Eastern J Med, 5, 48-51.
13. Kinnula VL, Crapo JD (2003). Superoxide dismutase in the lung and human lung disease. Am J Respir Crit Care Med, 167, 1600-19.
14. Klaunig JE, Xu Y, Isenberg JS, et al (1998). The role of oxidative stress in chemical carcinogenesis. Env Health Perspect, 106 (Suppl 1), 289-95.
15. Li H, Kantoff PW, Giovannuci E, et al (2005). Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. Cancer Res, 65, 2498-2504.
16. Liu J, Yeo HC, Overvick-Douki E, et al (2000). Chronically and acutely exercised rats: biomarkers of oxidative stress and endogenous antioxidants. J Appl Physiol, 89, 21-28.
17. Luo J (2001). Manganese superoxide dismutase (MnSOD) [paper]. Lowa: The University of Lowa.
18. Mariana (2007). Aktivitas enzim manganese superoxide dismutase (MnSOD) pada penderita karsinoma serviks sebelum dan setelah minggu ke-2 pemberian terapi kemoradiasi: hubungannya dengan polimorfisme gen MnSOD.[Masters Thesis.Jakarta:Fakultas Kedokteran Universitas Indonesia.
19. Mollerup S, Ryberg D, Skaug V, et al (2002). Lung cancer susceptibility. Norsk Epidemiologi, 12, 137-143.
20. Oberley TD (2002). Oxidative damage and cancer. Am J Pathol, 160, 403-408.
21. Pasupathi P, Saravanan G, Bakthavathsalam G (2008). Effect of chronic smoking on erythrocyte lipid peroxidation and antioxidant status in gastric carcinoma patients. J Cell Tissue Research, 8, 1399-1403.
22. Rajesh M, Sulochana KN, Coral K, et al (2004). Determination of carbonyl group content in plasma protein as a useful marker to assess impairment in antioxidant defense in patients with Eales' disease. Indian J Ophtalmology, 52, 139.
23. Remmen HV, Ikeno Y, Hamilton M, et al (2003). Life long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol Genomic, 16, 29-37.
24. Reth M (2007). Antioxidant defences: endogenous and diet derived. In:Halliwell B, Gutteridge JMC editors. Free radicals in biology and medicine. New York: Oxford University Press Inc, p.46-87.
25. Saintot M, Astre C, Pujol H, et al (1996). Tumor progression and oxidant-antioxidant status. Carcinogenesis, 17, 1267-1.
26. Sharma A, Rajappa M, Saxena A, et al (2007). Antioxidant status in advanced cervical cancer patients undergoing neoadjuvant chemoradiation. Br J Biomed Sci, 64, 23-7.
27. Sudoyo AW, Setiyohadi B, Alwi I, et al (2006). Buku ajar ilmu penyakit dalam jilid II edisi 4. Jakarta: Pusat Penerbitan Ilmu Penyakit Dalam FKUI,1005-1011.
28. Sun S, Schiller JH, Spinola M, Minna JD (2007). New molecularly targeted therapies for lung cancer. Clin Invest, 117, 2740.
29. Wanandi SI, Syahrudin E, Paramita R (2008). Hubungan genotipe dan ekspresi gen manganese superoxide dismutase pada penderita kanker paru dengan riwayat sebagai perokok.[Grants Research].Jakarta:Fakultas Kedokteran Universitas Indonesia.
30. Wang LI, Miller DP, Sai Y, et al (2001). Manganese superoxide dismutase alanin to valine polymorphism at codon 16 and lung cancer risk. J Natl Cancer Inst, 93, 1818-21.
31. Wills ED (1966). Evaluation of lipid peroxidation in lipids and biological membranes. Biochem Toxicol, 99, 667.
32. Winterbourn CC, Bonham MJD, Buss H, et al (2003). Elevated protein carbonyls as plasma markers of oxidative stress in acute pancreatitis. Pancreatology, 3, 375-82.
33. Winterbourn CC, Buss H, Chan TP, et al (2008). Protein carbonyl measurements show evidence of early oxidative stress in critically ill patients. Crit Care Med, 28, 143-9.
34. Yagci R, Ersoz I, Erdurmus M, et al (2008). Protein carbonyl levels in the aqueous humour and serum of patients with psedoexfoliation syndrome. Eye, 22, 128-31.